Search results for "Highlights"


 
Results 1 - 10 of about 418 for "Highlights".
Sort by: Relevance | Newest | Oldest

Portable point-of-care screening may help improve diabetic retinopathy diagnosis

An Australian study found that 39.6% of patients at high-risk diabetes clinics had diabetic retinopathy and 15.8% had vision-threatening diabetic retinopathy, previously undiagnosed in 59.3% and 62.8%, respectively.
https://diabetes.acponline.org/archives/2023/09/08/3.htm
8 Sep 2023

Subscribe

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.
https://diabetes.acponline.org/subscribe/index.html

Liraglutide shows some benefits as adjunctive therapy in type 1 diabetes, review finds

A systematic review and meta-analysis of studies involving four glucagon-like peptide-1 receptor agonists found that liraglutide had the greatest effect on HbA1c level, weight, and total insulin dose, although odds of nausea and ketosis were higher.
https://diabetes.acponline.org/archives/2023/09/08/2.htm
8 Sep 2023

Report and study highlight risk of heart failure in patients with diabetes

The American Diabetes Association made recommendations on diagnosing and treating heart failure in patients with diabetes, and a study found increased risk of progression to clinical heart failure in those with an HbA1c level of 7% or above.
https://diabetes.acponline.org/archives/2022/06/10/1.htm
10 Jun 2022

Oral care associated with lower risk of heart failure in patients with diabetes

Patients with type 2 diabetes who received a professional dental cleaning at least once a year and brushed their teeth at least twice a day had lower risk of developing heart failure than those who didn't, even if they were missing teeth.
https://diabetes.acponline.org/archives/2023/09/08/1.htm
8 Sep 2023

SGLT-2 inhibitors, GLP-1 receptor agonists beat DPP-4s, sulfonylureas in pragmatic trial

Veterans with diabetes who started sodium-glucose cotransporter-2 (SGLT-2) inhibitors or glucagon-like peptide-1 (GLP-1) receptor agonists had fewer major adverse cardiovascular events than those initiating dipeptidyl peptidase-4 (DPP-4) inhibitors or sulfonylureas.
https://diabetes.acponline.org/archives/2023/08/11/3.htm
11 Aug 2023

Young adults' lack of regular diabetes care may be linked to beliefs about medication

Follow-up research from the TODAY study found that a quarter of participants, ages 19 to 31 years, lacked a usual place for diabetes care and almost half had an urgent care visit in the past year. Belief in the necessity of medications was associated with regular access to care.
https://diabetes.acponline.org/archives/2023/08/11/2.htm
11 Aug 2023

Younger, leaner patients may have undiagnosed type 2 diabetes, study finds

An analysis of 56 national health surveys throughout the world found that a substantial proportion of patients with a fasting plasma glucose level of 126 mg/dL (7.0 mmol/L) or greater may be younger than age 35 years and/or be in the underweight or normal weight category.
https://diabetes.acponline.org/archives/2023/07/14/3.htm
14 Jul 2023

More than a quarter of diabetes patients have diabetic retinopathy, study estimates

Researchers calculated that in 2021, 9.60 million people in the U.S. had diabetic retinopathy, including 1.84 million with vision-threatening diabetic retinopathy, based on data from the National Health and Nutrition Examination Survey and insurance claims, among other sources.
https://diabetes.acponline.org/archives/2023/07/14/2.htm
14 Jul 2023

Strength training outperforms aerobic exercise in normal-weight type 2 diabetes patients

A randomized controlled trial in California found that glycemic control and body composition improved more over nine months among normal-weight patients with type 2 diabetes assigned to strength training versus aerobic exercise.
https://diabetes.acponline.org/archives/2023/08/11/1.htm
11 Aug 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next